March 2013
Janet P. Tate, ScD
CURRICULUM VITAE
Janet P. Tate, ScD
Yale University
Address: VA Connecticut Healthcare System
950 Campbell Ave, 11-ACSLG
West Haven, CT 06516
Phone: (203) 932-5711 ext 5371
Fax:
(203) 937-4926
Email: Janet.Tate2@va.gov
Education
BS
Southern Connecticut State University
MPH University of Connecticut
1997
ScD Harvard University
2010
1981
Career/Academic Appointments
1981-84
Development Chemist, MacDermid Inc., Waterbury, CT
1986-90
Analytical Chemist, Uniroyal Chemical, Naugatuck, CT
1990-92
Product Quality Analyst, Chemtura, Middlebury, CT
1992-94
Business Analyst, Chemtura, Middlebury, CT
1996-97
Research Fellow (0.4 FTE), Dept. of Community Medicine, Univ. of Connecticut Health Center
1997-07
Senior Health Information Analyst, Qualidigm, Rocky Hill, CT
2008-2011 Consultant statistician, Veterans Aging Cohort Study, Yale University, New Haven, CT
2008-2011 Consultant statistician (<0.1 FTE), Dept. of Cardiology, Univ. of Connecticut Health Center
2011Associate Research Scientist, Department of Internal Medicine, Yale Univ. School of
Medicine
Professional Honors & Recognition
1992
Quality Award, Uniroyal Chemical, Product excellence team concept
1991
Technical Achievement, Uniroyal Chemical, Naugard Q characterization and production
increase
1990
Tech Expo, Best Paper, Uniroyal Chemical, Characterization of TMQ antioxidants
1987
Technical Achievement, Uniroyal Chemical, Reduced variability of Vitavax assay method
Grant History
A. Current Grants
Agency: NIH/ NIAAA
I.D. #:
1U24AA020794
Title:
Consortium to improve OutcoMes in HIV/AIDS, Alcohol, Aging, & Multi-Substance Use
P.I.:
Amy Justice, MD, PhD, MSC
Role:
Director Biostatistics
Percent effort:
20%
Direct costs per year: $ 757,364
Project period:
09/1/2011 – 08/31/2016
1
March 2013
Janet P. Tate, ScD
Agency: NIH/ NHLBI
I.D. #:
3R01HL095136-04S1
Title:
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans - Supplement
P.I.:
Matthew Freiberg, MD
Role:
Biostatistician
Percent effort:
10%
Direct costs per year: $128,513
Project period:
09/25/2008 – 06/30/2013
Agency: NIH/ NIAID
I.D. #:
5U01A1069918
Title:
North American AIDS Cohorts Collaboration on Research and Design
P.I.:
Richard Moore, MD, MHS
Role:
Biostatistician
Percent effort:
15%
Direct costs per year: $49,172
Project period:
07/01//06 – 06/30/16
Agency: NIH/ NIAAA
I.D. #:
U24 AA022007-01
Title:
The Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA
P.I.:
R. Scott Braithwaite, MD, MSc, FaCP
Role:
Site PI, Biostatistician
Percent effort:
25%
Direct costs per year: $47,821
Project period:
09/1/12 – 8/31/17
Agency: NIH/ NIDA
I.D. #:
R01DA035616
Title:
Using the VACS Index to track health outcomes associated with changes in drug use
P.I.:
David Fiellin, MD
Role:
Biostatistician
Percent effort:
25%
Direct costs per year: $530,959
Project period:
04/01/13 - 02/29/16
B. Past Grants
Agency: NIH
I.D. #:
R01HS018372-02
Title:
Clinical Prediction of Hepatotoxicity&Comparative Hepatic Safety of Medications
P.I.:
Vincent LoRe III, MD, MSCE
Role
Statistician
Percent effort: 10%
2
March 2013
Janet P. Tate, ScD
Direct costs per year: $ 70,000
Project period:
08/01/11 - 07/31/12
Agency: NIAAA
I.D. #:
5U10AA013566-10
Title:
Alcohol Associated Outcomes Among HIV+/- Veterans
P.I.:
Amy Justice, MD, PhD, MSC
Role
Consultant
Percent effort: 99.9%
Direct costs per year: $ 2,519,900
Project period:
09/30/06 - 8/31/11
Agency: NIEHS
ID #:
2 T32 ES07069-26
Title:
Training Program in Environmental Epidemiology
PI:
David Christiani, MD, MPH, MS
Role:
Student
Project period
9/1/2005 – 8/31/2007
Agency:
ID#
Title:
PI:
Role:
Project period:
Department of Public Health, State of Connecticut
2009-0914 for Biomedical Research, 10/1/2009-6/30/2010
Development of a new blood test for patients with heart failure
Bruce Liang MD
Consultant Bio-statistician
10/1/2009-6/30/2010
Lectures, Courses, Web-based Education
2012 Introduction to Biostatistics in Clinical Research (2 lectures), Yale University School of Medicine
2011 Interpretation of diagnostic tests, Yale University School of Medicine Residents, Bridgeport Hospital
2010 Interpretation of diagnostic tests, Yale University School of Medicine Residents, Bridgeport Hospital
2010 Power and sample size, University of Connecticut School of Medicine, Cardiology and Pulmonary
Fellows
2008 Principles of Epidemiology, University of Connecticut MPH program, Farmington, CT
2006 Principles of Epidemiology, University of Connecticut MPH program, Farmington, CT
2005 Epidemiology Research Appraisal, University of Connecticut MPH program, Farmington, CT
2005 Principles of Epidemiology, University of Connecticut MPH program, Farmington, CT
2003 Principles of Epidemiology, University of Connecticut MPH program, Farmington, CT
2002 Principles of Epidemiology, University of Connecticut MPH program, Farmington, CT
Bibliography
1. Gregorio DI, Walsh SJ, Tate JP. Diminished socioeconomic and racial disparity in the detection of earlystage breast cancer, Connecticut, 1986-1995. Ethn Dis. 1999 Autumn;9(3):396-402.
2. Meehan TP, Chua-Reyes JM, Tate J, Prestwood KM, Scinto JD, Petrillo MK, Metersky ML. Process of
care performance, patient characteristics, and outcomes in elderly patients hospitalized with communityacquired or nursing home-acquired pneumonia. Chest. 2000 May;117(5):1378-85.
3
March 2013
Janet P. Tate, ScD
3. Graff L, Russell J, Seashore J, Tate J, Elwell A, Prete M, Werdmann M, Maag R, Krivenko C, Radford M.
False-negative and false-positive errors in abdominal pain evaluation: failure to diagnose acute
appendicitis and unnecessary surgery. Acad Emerg Med. 2000 Nov;7(11):1244-55.
4. Metersky ML, Tate JP, Fine MJ, Petrillo MK, Meehan TP. Temporal trends in outcomes of older patients
with pneumonia. Arch Intern Med. 2000 Dec 11-25;160(22):3385-91.
5. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ. Prevalence and
quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med.
2001 Nov 12;161(20):2458-63.
6. Harrold LR, Gurwitz JH, Tate JP, Becker R, Stuart T, Elwell A, Radford M. Physician attitudes
concerning anticoagulation services in the long-term care setting. J Thromb Thrombolysis. 2002
Aug;14(1):59-64.
7. Meehan TP, Tate JP, Holmboe ES, Teeple EA, Elwell A, Meehan R, Petrillo MK, Huot SJ. A
collaborative initiative to Improve the care of elderly patients with hypertension. Am J Med Qual. 2004
May-Jun;19(3):103-11.
8. Van Hoof TS, Pearson DA, Sherwin TE, Tate JP, Elwell A, Barr JK, Meehan TP. “Lessons learned from
performance feedback by a Quality Improvement Organization.” J Healthc Qual 2006; 28:20-31.
9. Holmboe ES, Wang Y, Tate JP, Meehan TP. “The effects of patient volume on the quality of diabetic care
for Medicare beneficiaries.” Med Care. 2006 Dec;44(12):1073-7.
10. Meehan TP, Wang Y, Tate JP, Curry M, Elwell A, Petrillo MK, Holmboe ES. “Improving the quality of
preventive cardiovascular care provided by primary care physicians: Insights from a U.S. Quality
Improvement Organization.” Int J Qual Health Care 2006;18(3):186-194.
11. Holmboe ES, Wang Y, Meehan TP, Tate JP, Ho SY, Starkey KS, Lipner RS. “Association between
maintenance of certification examination scores and quality of care for Medicare beneficiaries. Arch
Intern Med. 2008 Jul 14;168(13):1396-403.
12. Ohl M, Tate J, Duggal M, Skanderson M, Scotch M, Kaboli P, Vaughan-Sarrazin M, Justice A. Rural
Residence Is Associated With Delayed Care Entry and Increased Mortality Among Veterans With Human
Immunodeficiency Virus Infection. Med Care. 2010 Dec; 48(12):1064-1070.
13. Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, Fraenkel L, Mattocks K, Rimland D,
Rodriguez-Barradas MC, Tate J, Yin MT, Justice AC; for the Veterans Aging Cohort Study Project Team.
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans. PLoS
One. 2011 Feb 16;6(2):e17217
14. Lo Re V, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB, Rimland D, Rodriguez-Barradas MC,
Butt AA, Gibert CL, Brown ST, Kidwai F, Brandt C, Dorey-Stein Z, Reddy KR, Justice AC. Validity of
diagnostic codes and liver-related laboratory abnormalities to identify hepatic decomposition events in the
Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011 Jul; 20(7):689-699. [PMID:
21626605]
15. Park LS, Tate JP, Justice AC, Lo Re V, Lim JK, Brau N, Brown ST, Butt AA, Gibert C, Goetz MB,
Rimland D, Rodriguez-Barradas MC, Dubrow R. FIB-4 index is associated with hepatocellular carcinoma
risk in HIV-infected patients. Cancer Epidemiol Biomarkers Prev 2011 Dec; 20(12):2512-2517. [PMID:
22028407]
16. Tetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K Justice AC, Fiellin DA for the
Veterans Aging Cohort Study Project Team. Hepatic safety and antiretroviral effectiveness in HIV4
March 2013
Janet P. Tate, ScD
infected patients receiving naltrexone. Alcohol Clin Exp Res 2012 Feb; 36(2):318-324. [PMID:
21797892]
17. Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA,
Rodriguez-Barradas MC, Gibert C, Oursler KA, Deeks SG, Bryant K, and the VACS Project Team. Does
an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation
on mortality among those aging with HIV? Clin Infect Dis 2012; Feb 15 (Epub ahead of print). [PMID:
22337823]
18. Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC,
Sterling TR, Crane H, Kitahata MM, May M, Sterne JAC. The VACS index: An internationally
generalizable risk index for mortality after one year of antiretroviral therapy, in HIV-infected individuals.
AIDS 2013 Feb; 27(4):563-572. PMID: 23095314.
19. Justice AC, Modur S, Tate JP, Althoff KN, Jacobson LP, Gebo K, Kitahata M, Horberg M, Brooks J,
Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron J, Willig JH, Moore R, Kirk GD, Bosch R,
Rodriguez B, Hogg RS, Thorne J, Goedert JJ, Klein M, Gill MJ, Deeks S, Sterling TR, Anastos K, Gange
SJ for the NA-ACCORD and VACS Project Teams. Predictive accuracy of the Veterans Aging Cohort
Study (VACS) Index for mortality with HIV infection: A North American Cross Cohort Analysis. J Aquir
Immune Defic Syndr 2013 Feb; 62(2):149-163. PMID: 23187941.
20. Akgun KM, Gordon K, Pisani M, Fried T, McGinnis KA, Tate JP, Butt AA, Gibert CL, Huang L,
Rodriguez-Barradas MC, Rimland D, Justice AC, Crothers K. Risk factors for hospitalization and
medical intensive care unit (MICU) admission among HIV infected veterans. J Aquir Immune Defic
Syndr 2013 Jan; 62(1):52-59. PMID: 23111572.
21. Akgun KM, Tate JP, Pisani M, Fried T, Butt AA, Gibert CL, Huang L, Rodriguez-Barradas MC, Rimland
D, Justice AC, Crothers K. Medical Intensive Care Unit (MICU) admission diagnoses and outcomes in
HIV-infected and uninfected veterans in the combination antiretroviral era. Crit Care Med 2013; Mar 15
(Epub ahead of print). PMID: 23507717.
22. Oursler KK, Tate J, Gill TM, Crothers K, Brown TT, Crystal S, Womack J, Leaf DA, Sorkin JD, Justice
AC. Association of the VACS index with exercise capacity in HIV-infected adults. AIDS Res Hum
Retroviruses (in press).
Peer Reviewer Journals
Pharmacoepidemiology and Drug Safety
PLoS ONE
Clinical Infectious Diseases
5